Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors.
about
Nitromusk and polycyclic musk compounds as long-term inhibitors of cellular xenobiotic defense systems mediated by multidrug transporters.Annexin2 coating the surface of enlargeosomes is needed for their regulated exocytosis.Recent advances in pharmacokinetic extrapolation from preclinical data to humans.Multiple drugbinding sites on the R482G isoform of the ABCG2 transporter.Computational predictive models for P-glycoprotein inhibition of in-house chalcone derivatives and drug-bank compounds.Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function.Clinical significance of ABCB1 genotyping in oncology.Structure and function of efflux pumps that confer resistance to drugsPolymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemiaAbsorptive interactions of concurrent oral administration of (+)-catechin and puerarin in rats and the underlying mechanisms.Synthesis and small-animal positron emission tomography evaluation of [11C]-elacridar as a radiotracer to assess the distribution of P-glycoprotein at the blood-brain barrierComparative Study on the MDR Reversal Effects of Selected Chalcones.Neurobiological applications of small molecule screening.Defining targets for investigating the pharmacogenomics of adverse drug reactions to antifungal agents.Abcb1 in Pigs: Molecular cloning, tissues distribution, functional analysis, and its effect on pharmacokinetics of enrofloxacin.Synergistic effects of A-B-C-type amphiphilic copolymer on reversal of drug resistance in MCF-7/ADR breast carcinoma.Biomimetic synthesis and HPLC-ECD analysis of the isomers of dracocephins A and BABC transporters in human lymphocytes: expression, activity and role, modulating factors and consequences for antiretroviral therapies.Antiretroviral drug toxicity in relation to pharmacokinetics, metabolic profile and pharmacogenetics.Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system.Drug interactions with phytotherapeutics in oncology.Subtherapeutic ganciclovir (GCV) levels and GCV-resistant cytomegalovirus in lung transplant recipients.Photochemical activation of drugs for the treatment of therapy-resistant cancers.Altered intracellular pH regulation in cells with high levels of P-glycoprotein expression.(11)C- and (18)F-Labeled Radioligands for P-Glycoprotein Imaging by Positron Emission Tomography.Zosuquidar and an albumin-binding prodrug of zosuquidar reverse multidrug resistance in breast cancer cells of doxorubicin and an albumin-binding prodrug of doxorubicin.In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein.In vitro and in vivo evaluation of the effects of duloxetine on P-gp function.Multidrug resistance reversal properties and cytotoxic evaluation of representatives of a novel class of HIV-1 protease inhibitors.YC-1, a novel potential anticancer agent, inhibit multidrug-resistant protein via cGMP-dependent pathway.Cholesterol but not association with detergent resistant membranes is necessary for the transport function of MRP2/ABCC2.Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer.Characterization of an ABCG-like transporter from the protozoan parasite Leishmania with a role in drug resistance and transbilayer lipid movement.Emodin reverses leukemia multidrug resistance by competitive inhibition and downregulation of P-glycoprotein.Polar Quassinoids in Standardized Eurycoma longifolia Extract Formulated into a Lipid-Based Solid Dispersion to Improve Rat Sperm Count.Role of P-glycoprotein in the uptake/efflux transport of oral vitamin K antagonists and rivaroxaban through the Caco-2 cell model.Toxicokinetics and toxicodynamics of chlorpyrifos is altered in embryos of Japanese medaka exposed to oil sands process-affected water: evidence for inhibition of P-glycoprotein.Synthesis, Reactivity, Functionalization, and ADMET Properties of Silicon-Containing Nitrogen Heterocycles.Crown ethers reverse P-glycoprotein-mediated multidrug resistance in cancer cells
P2860
Q24811210-97161D88-B49B-4E7C-B86C-D36E37AAA9CAQ30478418-648D5F27-0B39-4D9D-8828-F36AAC0B96C8Q31049599-87710C58-EEFA-4FE6-A39C-1A3AC596F449Q33257856-11DF27DD-FA10-4010-B363-247E45D0E89EQ33458433-45198F2B-39D0-45F3-9571-23E6369D229CQ33559358-7B2B1182-BB04-44A3-8A08-F8FE37386A53Q33951034-0415D05D-FDFD-42FE-BCAE-9EA07CF0BB23Q35294152-D0141C76-D1EE-4FFC-9787-65D219AAE73EQ36605135-AABB50D0-7084-4F6A-AA23-EC76C8B6EED2Q36765130-F639AD95-E2E3-40B2-AF2D-38B443803331Q36949089-5328CF6C-63A8-4442-A9D9-04BACF2D4FE0Q37146490-76A7FB18-426A-446B-8020-76745300F99EQ37151213-B3D6BA55-3F70-4332-BB2D-3250EFC413C9Q37157893-D96B03F2-DB01-4E5B-A799-74B91EF1073BQ37215781-979CDFF2-D97D-4E72-9F82-62F05BAA0AB4Q37344258-7AA7F7C8-E3C6-4A79-A243-58FF5AE9A9F7Q37587821-22C65F2A-1DD4-47EB-A872-E936CAAC016EQ37724178-F54DE979-21E6-457A-8E81-EE97164DDDC8Q37866298-23DE67A0-1C47-40D3-9C2A-4D23359E4885Q38165880-F21BFD0F-BB9C-452C-A31E-A195CD14ACBFQ38175476-1DBE1A30-26D8-443E-94E4-D7419EA95CE4Q38285782-09C9B620-8389-4B5C-A301-261403DC323CQ38409528-698571E4-AC16-407B-8C2B-126A82A61B43Q38704242-CA10B1C6-0A89-407C-88AD-DF3C7CD2B374Q38819790-40BDE026-2A65-4BA7-BB01-E2C9991A047EQ39415463-850FF770-9680-413C-B3DF-538C6E8F0DD0Q39520772-75D2BB8B-0E42-4814-A206-2A9C53DAB16CQ39594120-A50F4B03-42D1-4976-BA21-5F47921157D6Q39635266-91D2C793-C7E8-443D-AC2A-399E41B86436Q39672848-79B4C94E-CDEB-4517-8D83-F5BCF954E73BQ39911534-E4359A2C-BC6D-48EB-B56D-65483AB01E18Q41368134-96F0FB3B-D0BD-48FB-B789-64C2FF73EB51Q41940537-1D9971E8-7A0D-4DD8-84E2-49E70328A085Q47110075-8F3877F5-F70A-49D5-AAFB-F8A7811E5996Q48289518-46361FE4-8EDB-4B03-9145-2C05B320AB45Q51003968-73C0E2C2-F83A-4E2E-BBD8-10752A455D22Q51367359-C8A39683-4F2C-4AAE-957E-F48DB5B08E9BQ55361717-1932F398-A9F3-4641-B4E0-CC2FD1E1B2E1Q59128986-03B49BC4-F976-4AA5-A403-30D70E70DD88
P2860
Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors.
@ast
Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors.
@en
type
label
Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors.
@ast
Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors.
@en
prefLabel
Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors.
@ast
Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors.
@en
P2093
P1476
Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors.
@en
P2093
P304
P356
10.1046/J.1365-2710.2003.00487.X
P577
2003-06-01T00:00:00Z